Business Technology

All Latest thinking

How the new connected era is reshaping biopharma

The health industry has not always been a leader in technology adoption. The current “high touch” model where caretakers deliver services within silos of care cannot be sustained because of high costs and other concerns. Making this even more of a challenge is a payment system that leaves little room for improved performance due to financial incentives. That’s changing and the industry is moving toward greater “connectedness.” 

This new model will feature these characteristics: data-based transparency, personalized care, and consumer-directed care. Strategies such as predictive medicine and personalized care could allow players to create value in this new environment. This report outlines how executives should react and take advantage.


Related insight

reportHealth care industry trajectory and strategy

Navigating a changing health-care environment

Pfizer’s Kristin Peck offers her perspectives on the industry’s new trajectory and describes how pilot programs, partnerships, and new investments will shape Pfizer’s strategy in the emerging era of connected health.